Integrating semaglutide into obesity management - a primary care perspective.
Publication/Presentation Date
1-1-2022
Abstract
This final article in the supplement aims to summarize a clinical approach for weight management geared toward primary care practitioners, offering practical advice about how to integrate weight management into day-to-day practice. To achieve long-term successful weight loss, a comprehensive multimodal approach is recommended, focusing on both lifestyle modification and appropriate use of therapy. Once-weekly subcutaneous semaglutide 2.4 mg is a novel treatment that can be used as an adjunct to lifestyle modification for the management of overweight and obesity. Key considerations are presented to support its optimal administration in conjunction with lifestyle modification, with a focus on assessing suitability and the importance of dose escalation and monitoring.
Volume
134
Issue
sup1
First Page
37
Last Page
49
ISSN
1941-9260
Published In/Presented At
Kyrillos, J. V., Skolnik, N. S., Mukhopadhyay, B., & Pennings, N. (2022). Integrating semaglutide into obesity management - a primary care perspective. Postgraduate medicine, 134(sup1), 37–49. https://doi.org/10.1080/00325481.2022.2149964
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
36691306
Department(s)
Administration and Leadership
Document Type
Article